[1] JOSE CRUZ-JENTOFT A, BAHAT G, BAUER J M, et al. Sarcopenia: revised European consensus on definition and diagnosis[J]. Age Ageing, 2019, 48(1):16-31.
[2] WANG T T, FENG X, ZHOU J J,et al. Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly[J]. Sci Rep, 2016. DOI: 10.1038/srep38937.
[3] KIM K S, PARK K S, KIM M J, et al. Type 2 diabetes is associated with low muscle mass in older adults[J]. Geriatr Gerontol Int, 2014, 14(Suppl1):115-121.
[4] TANAKA K, KANAZAWA I, SUGIMOTO T. Reduction in endogenous insulin secretion is a risk factor of sarcopenia in men with type 2 diabetes mellitus[J]. Calcif Tissue Int, 2015, 97(4):385-390.
[5] CETRONE M, MELE A, TRICARICO D. Effects of the antidiabetic drugs on the age-related atrophy and sarcopenia associated with diabetes type II[J]. Curr Diabetes Rev, 2014, 10(4):231-237.
[6] LEE C G, BOYKO E J, BARRETT-CONNO E, et al. Insulin sensitizers may attenuate lean mass loss in older men with diabetes[J]. Diabetes Care, 2011, 34(11):2381-2386.
[7] ABDULLA H, PHILLIPS B, SMITH K, et al. Physiological mechanisms of action of incretin and insulin in regulating skeletal muscle metabolism[J]. Curr Diabetes Rev, 2014, 10(5) 327-335.
[8] MELE A, CALZOLARO S, CANNONE G, et al. Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle[J]. Pharmacol Res Perspect, 2014, 2(1):e00028.
[9] SHIMOKAWA H, MIURA M, NOCHIOKA K, et al. Heart failure as a general pandemic in Asia[J]. Eur J Heart Fail, 2015, 17(9):884-892.
[10] FÜLSTER S, TACKE M, SANDEK A, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)[J]. Eur Heart J, 2013, 34(7):512-519.
[11] BEKFANI T, PELLICORI P, MORRIS D A, et al. Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life[J]. Int J Cardiol, 2016, 222:41-46.
[12] SANDRI M. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome[J]. Int J Biochem Cell Biol, 2013, 45(10):2121-2129.
[13] SABEL M S, LEE J, CAI S J, et al. Sarcopenia as a prognostic factor among patients with stage III melanoma[J]. Ann Surg Oncol, 2011, 18(13):3579-3585.
[14] WAN F N, ZHU Y, GU C Y, et al. Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer[J]. World J Surg Oncol, 2014, 12(1):14.
[15] FUKUMORI N, YAMAMOTO Y, TAKEGAMI M, et al. Association between hand-grip strength and depressive symptoms: Locomotive Syndrome and Health Outcomes in Aizu Cohort Study (LOHAS)[J]. Age Ageing, 2015, 44(4):592-598.
[16] WU H M, YU B, MENG G, et al. Both muscle mass and muscle strength are inversely associated with depressive symptoms in an elderly Chinese population[J]. Int J Geriatr Psych, 2016, 32(7):769-778.
[17] HSU Y H, LIANG C K, CHOU M Y, et al. Association of cognitive impairment, depressive symptoms and sarcopenia among healthy older men in the veterans retirement community in southern Taiwan: a cross-sectional study[J]. Geriatr Gerontol Int, 2014,14(Suppl1):102-108.
[18] GARIBALLA S, ALESSA A. Sarcopenia: prevalence and prognostic significance in hospitalized patients[J]. Clin Nutr, 2013, 32(5):772-776.
[19] ANGLIN R E S, SAMAAN Z,WALTER S D, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis[J]. Br J Psychiatry, 2013, 202(2):100-107.
[20] 从晶晶, 何平. 老年类风湿性关节炎与肌少症相关性研究进展[J]. 实用老年医学, 2020, 34(3):220-224.
[21] 冯婷婷, 王佳贺. 骨质疏松与肌少症相关性研究进展[J]. 实用老年医学, 2020, 34(3):216-219. |
